## Abstract Methods provided by nuclear medicine may be helpful in diagnosis of Parkinson's disease (PD). For that purpose, the sensitivity of iodine‐123 metaiodobenzylguanidine ([123I]MIBG) scintigraphy and [123I]FP‐CIT single photon emission computed tomography (SPECT) was studied in patients wit
Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease
✍ Scribed by J. Spiegel; D. Hellwig; S. Samnick; W. Jost; M.-O. Möllers; K. Fassbender; C.-M. Kirsch; U. Dillmann
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 132 KB
- Volume
- 114
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The variability in clinical features and the masking effects of drug therapy in Parkinson's disease (PD) can affect clinical assessment of disease severity. The aim of this study was to assess the imaging of dopamine transporters using 123 I-FP-CIT SPECT and its correlation with disease staging, sev
Previous studies have utilized single-photon emission computed tomography (SPECT) to demonstrate decreased [1231] P-CIT striatal uptake in idiopathic Parkinson disease (PD) patients. The present study extends this work by examining SPECT outcome measures in a iarger group of PD patients with varying